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INTRODUCTION 
Carpal tunnel syndrome (CTS) is caused by the 
compression of median nerve in carpal tunnel. Carpal 
bones make the floor of the carpal tunnel and the 
transverse carpal ligament forms the roof. Components 
include median nerve and the flexor tendons. The pain 
may be localized to the wrist or may radiate to forearm, 
arm or rarely shoulder. Paresthesias are frequently 
present in medial thumb, index, middle and lateral ring 
finger. During sleep, paresthesias worsen due to 
increase in carpal tunnel pressure and nerve ischemia. 
The annual incidence of CTS is 0.1% among adults and 
prevalence is 2.7% in general population.(1,2) It 
frequently affects female more than male, literature 
review on demographic characteristics of CTS in 
Pakistan population revealed a ratio of 4.8:1 which is 
near to ratio of 5.6:1 in a study done by Gomes in 
Brazil, reason being female population have small 
carpal tunnels compared to males.(1,3) Etiology is likely 
related to occupations involving excessive use of hand 
or wrist like in typists, mechanics, carpenters. An 
interesting study done on prevalence of CTS in dentists 
working in Karachi, revealed prevalence of 10.31% (4) 
Similar literature on association of CTS with the specific 
occupation can be found in laboratory workers in India 
with the prevalence of 21.5% and in Saudi Arabia it 
was 25.3% (5,6) This high prevalence reflects significant 
association of CTS with the occupation.  Risk factors of 
CTS include diabetes, obesity, age, pregnancy, 
hypothyroidism, rheumatoid arthritis, gout, acromegaly, 
amyloidosis, arterio-venous shunts for hemodialysis 
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ABSTRACT 
BACKGROUND: Carpal tunnel syndrome (CTS) is caused by the compression of median nerve in carpal tunnel. Carpal 
bones make the floor of the carpal tunnel and the transverse carpal ligament forms the roof. Components include 
median nerve and the flexor tendons. The pain may be localized to the wrist or may radiate to forearm, arm or rarely 
shoulder. Effectiveness of treatment by intracarpal corticosteroid injection in comparison with NSAID has never been 
investigated. The objective of this study was to determine if corticosteroid injections for carpal tunnel syndrome are 
effective compared to NSAID.
METHODS: In this study 46 participants with a clinical diagnosis of CTS were recruited. Participants were randomly 
assigned treatment group A (intra carpal tunnel steroid injection) and B (NSAID) by coin flipping method. Main 
outcomes, mean score of the Symptom Severity Scale (SSS) of the Boston carpal tunnel questionnaire, subjective 
improvement during follow-up were collected. Duration of follow-up was 3 months.
RESULTS: The median duration of symptoms was 8 months in NSAID group and 7 months in Steroid group post 
treatment. Steroid group showed better direct treatment response (P=0.001) and perceived improvement (P=0.001) 
than the NSAID group in the outcomes. Symptom severity score improved significantly after steroid treatment 
compared to NSAID group, from (2.79 to 1.01) in steroid group versus (2.58 to 2.45) in NSAID group
CONCLUSION: Intracarpal tunnel steroids injection was more effective as compared to NSAID in management of 
carpal tunnel syndrome.
Key words: Carpal tunnel syndrome, steroids, NSAIDs
O R I G I N A L  A R T I C L E
Corresponding to: Saba Zaidi, Liaquat National hospital Email: drsabazaidi@gmail.com
Date of submission:  November 17, 2020 Date of revision:February 22, 2021 Date of acceptance: February 27, 2021
2 1P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 6  ( 1 )  J A N U A R Y - M A R C H  2 0 2 1
and fractures at the wrist. Diagnosis of CTS can be 
made clinically and confirmed by American Academy of 
Neurology (AAN) electro diagnostic criteria. (11) On 
examination sensory changes like impaired pin-prick 
and two point discrimination in the distribution of 
median nerve can be elicited. Symptoms can be 
reproduced by Phalen maneuver (7,8) (flexion at both 
wrists for 1 minute) and Reverse Phalen maneuver 
(hyperextension of the wrist). Percussion at the wrist 
causes paresthesias in the distribution of median nerve 
suggestive of positive Tinel’s sign is also a specific 
clinical sign of CTS. In severe cases patients develop 
muscle weakness and atrophy(9,10). Treatment of CTS 
includes oral analgesics, NSAIDS, wrist splinting, 
intra-carpal tunnel steroid injections or tendon release 
surgery. NSAIDs provide anti-inflammatory effects and 
reduces edema in carpal tunnel leading to relieve of 
symptoms. Though literature search showed limited 
benefit with NSAIDs in the management of CTS but 
NSAIDs still are considered first line for conservative 
management (12). 
METHODS:
Setting: Patients were recruited from the outpatient 
department of Ziauddin university hospital
Patient recruitment and inclusion/exclusion 
criteria:
Patients presenting with symptoms and signs 
suggestive of carpal tunnel syndrome were eligible for 
inclusion. Exclusion criteria were thenar atrophy, being 
less than 18 years of age, presence of 
contraindications for corticosteroid injection 
(hypersensitivity to corticosteroids, local skin infection), 
prior treatment for CTS in the last six months with 
steroid injection or surgery, traumatic or neoplastic 
origin of symptoms, co-existing diseases such as 
polyneuropathy, cervical radiculopathy and thoracic 
outlet syndrome, inability to fill in follow-up forms or 
absence of self-determination in the participant. After 
applying in- and exclusion criteria, written informed 
consent was obtained from participants by their general 
practitioner.
Randomization:
Through flip coin method
Outcome measurement:
1. Direct treatment response (based on consensus 
between physician and patient):
• 0 = no response
• 1 = partial response, but not satisfactory, warranting 
further treatment
• 2 = partial response, satisfactory, not warranting 
further treatment
• 3 = complete resolution of symptoms and signs
2. Improvement as perceived by patient:
• -2 = much worse
• -1 = worse
• 0 = not better/not worse
• + 1 = better
• + 2 = much better
Symptom severity was assessed by using the Symptom 
Severity Scale (SSS), which is the part of Boston Carpal 
Tunnel Questionnaire (BCTQ). The BCTQ is a 
patient-reported outcome measure for CTS and has 
been tested for validity, reliability and responsiveness. 
The SSS has 11 questions- use a five-point scale. Each 
scale generates a final score (sum of individual item 
scores divided by number of items), which ranges from 
1 to 5. Higher SSS correlate with more severe 
symptoms.
Follow up measurements were performed by sending 
questionnaires to participants 1, 3 months.
Sample size and data analysis:
At the significance level of 5%, power of the study 80%, 
percentage success in control NSAID group 50% and 
percentage success in experimental steroid group as 
86% (10), the sample size from sealed envelope was 
calculated to be 23 per group and total 46
RESULTS:
O R I G I N A L  A R T I C L E
Much better 17(37) 0(0) 17(73.9) 
Direct Treatment Response at 3 month       <0.001* 
No response 2(4.3) 2(8.7) 0(0) 
Partial response but not satisfactory, warranting 
further treatment 
21(45.7) 21(91.3) 0(0) 
Partial response but satisfactory, not warranting 
further treatment 
4(8.7) 0(0) 4(17.4) 
Complete resolution of symptoms and signs 19(41.3) 0(0) 19(82.6) 
Improvement as percieved by patient at 3 month       <0.001* 
Not better/not worse 22(47.8) 22(95.7) 0(0) 
Better 5(10.9) 1(4.3) 4(17.4) 
Much better 19(41.3) 0(0) 19(82.6) 
Characteristics Total  Intervention P-value 
Nsaid                              
23(50) 
Steroid                                       
23(50) 







Duration of symptoms 8.30±3.83 8.86±4.07 7.73±3.58 0.332** 
          
Gender       1.000** 
Male 16(34.8) 8(34.8) 8 (34.8) 
Female 30(65.2) 15(65.2) 15(65.2) 
Symptoms       0.038* 
Pain 17(37) 4(17.4) 13(56.5) 
Paesthesias 17(37) 12(52.2) 5(21.7) 
Tingling 8(17.4) 5(21.7) 3(13) 
Numbness 4(8.7) 2(8.7) 2(8.7) 
Phalen Test       0.233** 
Positive 43(93.5) 20(87) 23(100) 
Negative 3(6.5) 3(13) 0(0) 
Tinel Test       0.233** 
Positive 43(93.5) 20(87) 23(100) 
Negative 3(6.5) 3(13) 0(0) 
Symptom severity score         
Mean score at baseline 2.69±0.36 2.58±0.39 2.79±0.30 0.054** 
Mean score after 1 month 1.73±0.76 2.45±0.31 1.01±0.03 <0.001* 
Mean score  after 3 month 1.72±0.76 2.45±0.31 1.00±0.02 <0.001* 
Direct Treatment Response at 1 month       <0.001* 
No response 6(13) 6(26.1) 0(0) 
Partial response but not satisfactory, warranting 
further treatment 
17(37) 17(73.9) 0(0) 
Partial response but satisfactory, not warranting 
further treatment 
6(13) 0(0) 6(26.1) 
Complete resolution of symptoms and signs 17(37) 0(0) 17(73.9) 
Improvement as percieved by patient at 1 month       <0.001* 
Not better/not worse 22(47.8) 22(95.7) 0(0) 
Better 7(15.2) 1(4.3) 6(26.1) 
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Summary amain findings:
The median duration of symptoms was 8 months in 
NSAID group and 7 months in Steroid group. Steroid 
group showed better direct treatment response 
(P=0.001) and perceived improvement (P=0.001) 
than the NSAID group in the outcomes. Symptom 
severity score improved significantly after steroid 
treatment compared to NSAID group. From (2.79 to 
1.01) in steroid group versus (2.58 to 2.45) in NSAID 
group
Comparison with existing literature:
As far as isolated effect of Local steroid injections was 
concerned literature revealed that they have been 
proved effective for treating carpal tunnel syndrome. 
Patient satisfaction, clinical improvement , symptoms, 
function and pain were shown to improve after 
cortisone injections.(13-19) Similar to our study where we 
have proven superiority of steroid injections. Cochrane 
database systemic review showed that local 
corticosteroid injection for carpal tunnel syndrome 
provides greater clinical improvement in symptoms one 
month after injection compared to placebo. They also 
added that steroid injection provides significantly 
greater clinical improvement than oral steroid for up to 
three months. Two local corticosteroid injections do not 
provide significant added clinical benefit compared to 
one injection. (20, 21)  Another trial which is part of a larger 
study called the Groningen Hand and Wrist Injection 
Therapy Trial (HAWITT) evaluated the efficacy and 
feasibility of steroid injections for carpal tunnel 
syndrome, de Quervain's tenosynovitis and trigger finger 
in primary care. The results of this study suggest that 
intra-carpal tunnel injection with 1 ml 
triamcinolonacetonide 10 mg/ml are effective with 
respect to short-term outcomes when compared to 
placebo-injections in patients presenting to their 
general practitioner with a clinical diagnosis of CTS. 
Long-term effectiveness is less clear: the achieved 
treatment effects seem to diminish slowly in half of the 
cohort of patients that responded to steroid injections 
during the 12 months after the intervention and 
recurrences occurred in the other half of the cohort of 
steroid responders. When comparing the effectiveness 
of local steroid injection and carpal tunnel release 
operation for the treatment of CTS, local steroid 
injections give transient relief where as carpal tunnel 
release surgery provides long-lasting relief as shown in 
a short series of 40 patients with short-term follow-up 
of 12 weeks (22) Optimal treatment of CTS has not been 
established.This study compared the effects of local 
steroid injection versus surgical decompression in 
new-onset CTS of at least 3 months' duration. Both 
treatment groups had comparable severity of CTS at 
baseline. Eighty wrists were randomly assigned to the 
surgery group and 83 wrists to the local steroid 
injection group. In the intent-to-treat analysis, at 3 
months of follow-up, 94.0% of the wrists in the steroid 
injection group versus 75.0% in the surgery group 
reached a 20% response for nocturnal paresthesias (P 
= 0.001). At 6 and 12 months, the percentages of 
responders were 85.5% versus 76.3% (P = 0.163) 
and 69.9% versus 75.0% (P = 0.488), for local steroid 
injection and surgical decompression, respectively. 
Over the short term, local steroid injection is better than 
surgical decompression for the symptomatic relief of 
CTS. At 1 year, local steroid injection is as effective as 
surgical decompression for the symptomatic relief of 
CTS. Gurcay et al conducted a randomised clinical trial 
in patients with CTS, assessing functional findings and 
electrophysiologic examinations on initial visit and at 
the third month, comparing treatment either with 
NSAID or local steroid injection. The results showed 
that neither of the groups demonstrated superior 
efficacy. (23) These were contrary to our results.
Strength and limitations:
To our knowledge this is the first randomized clinical 
trial comparing efficacy of steroids with NSAID. Strong 
points in our study were that randomization was 
rigorous, we used valid patient assessment tool. Our 
trial did not include nerve conduction study because 
our study dependent on the clinical signs and 
symptoms of CTS. Due to small sample size our study 
cannot be generalizable for the population of patients 
presenting with CTS.
Conclusion 
In our opinion steroid injection into the carpal tunnel is 
a safe, easy to learn and apply therapeutic intervention 
and it is superior in efficacy compared to NSAID. We 
feel that initial treatment of patients with CTS should be 
intra carpal tunnel steroid injections.
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